Market Size (2025)
$600.70M
Vertical: CNMBase Year: 2025
Market Size (2025)
$600.70M
Projected (2032)
$1.17B
CAGR (2022–2032)
10.0%
Key Players
9+
Market Overview
The Global Baculovirus Biopesticides Market was valued at USD 600.70 Million in 2025 and is projected to reach USD 1,165.96 Million by 2032, registering a CAGR of 9.92% during the forecast period 2026–2032. The market has expanded steadily from USD 450.29 Million in 2022, and the absolute growth opportunity between 2025 and 2032 amounts to USD 565.26 Million.
Baculovirus biopesticides are microbial insecticides based on nucleopolyhedroviruses (NPVs) and granuloviruses (GVs) that infect and kill the larvae of specific insect pests, chiefly caterpillars of moths. Their high host specificity, absence of harmful effects on beneficial insects, pollinators, vertebrates and humans, and their exemption from maximum residue limits in many jurisdictions make them a valued tool in integrated pest management (IPM) and resistance management programmes. Demand is shaped by three structural forces: the growing incidence of insecticide resistance in major lepidopteran pests such as Helicoverpa armigera, Spodoptera frugiperda and Cydia pomonella; regulatory and retailer pressure to reduce chemical residues in food; and the spread of invasive pests, notably fall armyworm, into Africa and Asia.
Key Findings
Formulation: Liquid (SC) was the largest segment, accounting for 70.00% of the market in 2025 (USD 420.49 Million). It is also the fastest-growing formulation, with a CAGR of 10.77% over 2026–2032.
Crop Type: Fruits & Vegetables held the largest share at 50.00% in 2025 (USD 300.35 Million), while Cotton & Field Crops is the fastest-growing crop type at a CAGR of 11.34%.
Target Pest: Lepidoptera dominated with 90.00% of 2025 revenue (USD 540.63 Million); the Others segment is expanding faster, at a CAGR of 11.67%.
Region: North America was the leading region in 2025 with USD 198.23 Million (33.00% share). Middle East & Africa is the fastest-growing region, with a CAGR of 13.05%, followed by Asia Pacific at 12.28%.
Country: The U.S. was the leading country market in 2025 at USD 158.58 Million, while Saudi Arabia is the fastest-growing country, with a CAGR of 15.16% over 2026–2032.
Segmentation Summary
By formulation, the market is divided into Liquid (SC) and Dry products. Liquid suspension concentrates generated USD 420.49 Million in 2025 and are forecast to reach USD 862.81 Million by 2032, supported by their ease of tank mixing, uniform spray coverage and suitability for large-acreage application. Dry formulations, valued at USD 180.21 Million in 2025, remain important where ambient-temperature storage and lower freight cost are priorities, and are expected to grow at a CAGR of 7.72%.
By crop type, Fruits & Vegetables (USD 300.35 Million in 2025) represent the established core of the market, built on codling moth granulovirus in pome fruit and NPV products in tomatoes, peppers and brassicas. Cotton & Field Crops (USD 210.25 Million in 2025) are the principal growth engine, reflecting large-scale adoption of NPV products in soybean, maize and cotton, particularly in Brazil. The Others segment, covering forestry, ornamentals, nut and plantation crops, was valued at USD 90.11 Million in 2025.
By target pest, Lepidoptera account for the bulk of demand (USD 540.63 Million in 2025), since nearly all commercial baculoviruses are isolated from and target moth and butterfly larvae. The Others segment (USD 60.07 Million in 2025), which includes hymenopteran sawfly viruses used mainly in forestry, is projected to reach USD 130.59 Million by 2032.
Competitive Landscape Summary
The market is moderately fragmented. A small group of specialist producers with broad virus portfolios and international registrations – Andermatt Group AG, AgBiTech (part of BASF since March 2026) and Certis Biologicals (Mitsui & Co.) – leads the global market. They are joined by diversified crop protection and biocontrol companies such as UPL (through its NPP business unit), Koppert and Biobest (through Biotrop), and by regional producers such as Simbiose Agro and Promip in Brazil and River Bioscience in South Africa. Competition centres on breadth of virus isolates, registration coverage, production scale and cost, formulation stability and access to distribution channels. Since 2022 the industry has seen notable consolidation, including Andermatt's acquisitions of BioTEPP (Canada) and a majority stake in Agricheck (Argentina), Biobest's acquisition of Biotrop and BASF's acquisition of AgBiTech.
Challenges and Opportunities
The main challenges are the narrow host range of individual viruses, which limits each product to one or a few pest species; a slower speed of kill than synthetic insecticides; sensitivity to ultraviolet radiation, which shortens field persistence; and the cost and complexity of in vivo production in live insect larvae. Lengthy and divergent registration procedures across countries also slow market entry. On the other side, significant opportunities exist in large-acre row crops in Latin America and Asia, in multi-virus combination products that broaden the pest spectrum, in new resistance-breaking isolates, and in the integration of baculovirus products into the distribution networks of major agrochemical companies.
Future Outlook
The market is expected to nearly double between 2025 and 2032, rising from USD 600.70 Million to USD 1,165.96 Million. Growth will be strongest in emerging agricultural economies: Middle East & Africa (CAGR 13.05%) and Asia Pacific (CAGR 12.28%) are expected to outpace the global average, while Latin America (CAGR 10.35%) will add USD 125.70 Million in absolute terms. Mature markets in North America and Europe will continue to grow on the back of residue-free food standards, organic production and resistance management needs. Advances in formulation technology, improvements in production efficiency and the entry of large agrochemical companies are expected to make baculovirus products more widely available and more competitive with chemical alternatives over the forecast period.
The Baculovirus Biopesticides Market market is projected to grow at a CAGR of 10.0% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Baculovirus biopesticides are crop protection products whose active ingredient is a virus of the family Baculoviridae. Baculoviruses are rod-shaped, enveloped viruses with a large, circular, double-stranded DNA genome. The family comprises four genera: Alphabaculovirus (nucleopolyhedroviruses of Lepidoptera), Betabaculovirus (granuloviruses of Lepidoptera), Gammabaculovirus (nucleopolyhedroviruses of Hymenoptera) and Deltabaculovirus (nucleopolyhedroviruses of Diptera). Virions are embedded in protein crystals called occlusion bodies, which protect the virus in the environment. When a susceptible larva ingests occlusion bodies on treated foliage, the crystals dissolve in the alkaline midgut, the released virions infect midgut cells and the infection spreads systemically, killing the larva within several days. The disintegrating cadaver releases large numbers of new occlusion bodies that can infect further larvae.
Commercial baculovirus products are produced by multiplying the virus in live host larvae (in vivo production), harvesting and purifying the occlusion bodies, and formulating them as liquid suspension concentrates or dry products such as wettable powders and water-dispersible granules. Well-known active ingredients include Cydia pomonella granulovirus (CpGV), Helicoverpa armigera nucleopolyhedrovirus (HearNPV), Helicoverpa zea single nucleopolyhedrovirus (HzSNPV), Spodoptera frugiperda multiple nucleopolyhedrovirus (SfMNPV), Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV), Chrysodeixis includens nucleopolyhedrovirus (ChinNPV) and Plutella xylostella granulovirus (PlxyGV).
Included in the scope: registered baculovirus-based insecticidal products, in liquid and dry formulations, used in agriculture, horticulture, forestry and other crop and plant protection applications, including combination products containing more than one baculovirus.
Excluded from the scope: other microbial biopesticides such as Bacillus thuringiensis, entomopathogenic fungi and nematodes; semiochemicals and botanical insecticides; baculovirus expression vector systems used to manufacture vaccines, recombinant proteins and gene therapy vectors; and unregistered on-farm multiplication of viruses.
Scope of the Study
The study analyses the Global Baculovirus Biopesticides Market in terms of value (USD Million) across the following segmentations and geographies:
By Formulation: Liquid (SC); Dry
By Crop Type: Fruits & Vegetables; Cotton & Field Crops; Others
By Target Pest: Lepidoptera; Others
By Region: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)
Timeline: Historic years 2022–2024; base year 2025; forecast period 2026–2032
Currency: USD Million
Research Objectives
To estimate the size of the global baculovirus biopesticides market in value terms for the historic period 2022–2024 and the base year 2025, and to forecast it for 2026–2032.
To analyse the market by formulation, crop type and target pest, and to identify the largest and fastest-growing segments.
To assess the market across five regions and their major countries, and to identify the regional and country-level factors shaping demand.
To examine the drivers, restraints, opportunities, trends and challenges influencing the adoption of NPV- and GV-based products.
To evaluate the role of insecticide resistance management, residue regulations and invasive pest outbreaks in the uptake of baculovirus products.
To review the regulatory frameworks governing the registration of microbial pest control products in key markets.
To profile the competitive environment, including the positioning of leading companies and key developments since 2022.
To identify investment and growth opportunities for producers, distributors and other stakeholders across the value chain.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured, multi-stage research process. It began with a definition of the market scope and segmentation, followed by extensive secondary research to build an understanding of the product technology, the regulatory environment, the competitive landscape and the demand drivers in each region. The secondary findings were validated and refined through primary research with industry participants on both the supply and demand sides. Market size was then estimated using top-down and bottom-up approaches, triangulated, and projected over the forecast period using a factor-based forecasting model. The final estimates were reviewed for internal consistency across segments, regions and countries.
Secondary Research
Secondary research drew on a wide range of sources relevant to the biological crop protection industry, including:
Industry associations: biocontrol and crop protection associations such as the International Biocontrol Manufacturers Association (IBMA), the Biological Products Industry Alliance (BPIA), CropLife International and its regional members, and national biological inputs associations in Brazil and India.
Government and regulatory bodies: pesticide registration authorities and their product databases, including the U.S. EPA, Health Canada's PMRA, the European Commission and EFSA, Brazil's Ministry of Agriculture and Livestock (MAPA), India's Central Insecticides Board and Registration Committee (CIB&RC), China's ICAMA and Australia's APVMA, as well as agricultural statistics agencies.
Public research institutions: publications from Embrapa, USDA Agricultural Research Service, ICAR institutes and universities on baculovirus efficacy, production and field adoption.
Company sources: annual reports, investor presentations, press releases, product labels and technical bulletins of baculovirus producers and distributors.
Trade and scientific journals: peer-reviewed literature on insect virology and biological control, and agricultural trade publications covering product launches, registrations and transactions.
Paid databases: company financial databases, trade statistics and agricultural market databases used to cross-check crop area, pest pressure and crop protection spending.
Primary Research
Primary research was conducted through in-depth telephone and online interviews with industry participants. The objectives were to validate the market definition and segmentation, verify secondary data, obtain insights on pricing, volumes and adoption rates, and understand qualitative factors such as competitive strategy, regulatory developments and customer requirements.
Supply side: executives, product managers, regulatory affairs specialists and technical development managers at baculovirus manufacturers, formulators and biological crop protection companies, as well as distributors and importers.
Demand side: commercial growers of fruit, vegetables, cotton, soybean and maize, crop advisers and agronomists, farmer cooperatives, forestry managers and integrated pest management specialists.
Other experts: academic researchers in insect virology and biological control, extension specialists and representatives of public research institutions.
Market Size Estimation
Top-down approach: The overall biopesticides and bioinsecticides markets were used as a starting point, and the share attributable to baculovirus products was derived by region using registration data, company revenue information and expert input. The resulting regional values were then split by formulation, crop type and target pest.
Bottom-up approach: Revenues of leading baculovirus producers and distributors were estimated from company disclosures and interviews and aggregated by region and country. In parallel, demand-side estimates were built from treated crop area, application rates, number of applications per season and average product prices for key crop–pest combinations.
Data triangulation: The estimates from both approaches were compared and reconciled. Where discrepancies arose, the underlying assumptions were re-examined and validated through additional primary interviews until the supply-side and demand-side views converged within an acceptable range.
Forecasting Methodology
The forecast was developed using a factor-based model that combines historical market trends with an assessment of the drivers and restraints expected to influence demand over 2026–2032. Factors considered include: growth in treated area for key crops; trends in insecticide resistance; regulatory changes affecting synthetic insecticides and the approval of microbial products; organic and residue-free production trends; outbreaks of invasive pests; product pipeline and new registrations; price trends; and macroeconomic conditions in agriculture. Each factor was assigned a weight and impact by region, and the resulting growth rates were validated with industry experts.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024
Base year: 2025
Forecast period: 2026–2032; CAGR is calculated for 2026–2032
Currency: All values are presented in USD Million
Assumptions and Limitations
Market values are expressed at manufacturer and first-level distributor selling prices and exclude value added further down the distribution chain.
Values for non-U.S. markets are converted to U.S. dollars using average annual exchange rates; currency movements may affect reported values.
The forecast assumes no major disruption to agricultural trade or to regulatory frameworks for microbial pesticides in the key markets.
Private companies form a large part of the market and do not publicly disclose revenue; their contributions are estimated from interviews, registration data and secondary information.
Unregistered on-farm multiplication of viruses, which occurs in some countries, is not valued in this study.
The study reflects information available up to the time of publication; subsequent regulatory or market events are not included.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Baculovirus Biopesticides Market is moderately fragmented. At the global level, a small number of specialist companies with broad portfolios of virus isolates, multi-country registrations and dedicated production facilities account for a significant part of the market. Around them operates a large and diverse group of regional producers, particularly in Brazil, China, India and South Africa, many of which focus on one or two viruses for local crops and pests. Diversified biological control companies and major agrochemical groups are increasingly active, either through their own products, licensing and distribution agreements, or acquisitions.
Competition is based on the breadth and performance of virus isolates, registration coverage, production capacity and cost efficiency, product quality and formulation stability, technical support for growers and access to distribution channels. Because registrations and production know-how are difficult to replicate, acquisitions of companies holding registered products and manufacturing capabilities have become a common route to growth. The period since 2022 has been marked by a series of such transactions, culminating in BASF's acquisition of AgBiTech in 2026, which brings one of the leading baculovirus specialists into a global agrochemical group.
Key Player Positioning
Leaders
Andermatt Group AG (Switzerland): A privately owned company founded in 1988 whose first product, the codling moth granulovirus Madex, was authorised at the end of 1987. Andermatt offers the broadest baculovirus portfolio in the industry, including CpGV (Madex range, Virosoft CP4), HearNPV (Helicovex), SpliNPV (Littovir), SfMNPV (Spodovir Plus), SeMNPV (Spexit), ChinNPV (Loopovir), PlxyGV (Plutex), PhopGV (Tutavir) and CrleGV (Cryptex). It operates through a network of subsidiaries and production companies and has expanded through acquisitions and new subsidiaries in the Americas and Europe.
AgBiTech (USA; part of BASF since March 2026): Founded in Australia in 2000 and headquartered in Fort Worth, Texas, AgBiTech specialises in NPV products for caterpillar pests in soybean, maize and cotton, with products such as Heligen, Fawligen, Cartugen Max and the Surtivo range. Brazil is its most important market. BASF completed the acquisition of AgBiTech on 31 March 2026; BASF's Agricultural Solutions segment reported sales of EUR 9.6 billion in 2025.
Certis Biologicals (USA; Mitsui & Co.): A wholly owned subsidiary of Mitsui & Co. with a portfolio of more than 40 biological products, including the HzSNPV product Gemstar LC and the CpGV products CYD-X and CYD-X HP. In Europe, Mitsui's affiliate Certis Belchim markets crop protection products, including biologicals.
Challengers
UPL Ltd. – NPP business unit (India): UPL's Natural Plant Protection (NPP) unit, launched in 2021, markets the Carpovirusine range of CpGV products for codling moth and distributes AgBiTech's Heligen and Fawligen in parts of the western United States. UPL reported revenue from operations of INR 51,839 crore for FY2025–26.
Koppert (Netherlands): A global leader in biological control, Koppert markets the SfMNPV product Buick for fall armyworm in Brazil, alongside its broad portfolio of beneficial insects and microbial products.
Simbiose Agro (Brazil): One of Brazil's largest producers of biological inputs, with SfMNPV products such as VirControl Sf (developed with Embrapa) and Elagesk SF, and an investment programme of more than BRL 300 million announced in 2023 to expand capacity and international presence.
Niche Players
Biobest Group (Belgium) / Biotrop (Brazil): Biobest completed the acquisition of a majority stake in Biotrop in December 2023; Biotrop distributes SfMNPV products within its Brazilian biologicals portfolio.
Promip (Brazil): An industrial-scale producer of SfMNPV (BaculoMIP-SF) based on Embrapa technology, supplying the product to distribution partners under several brand names.
River Bioscience (South Africa): A grower-owned company producing baculoviruses for false codling moth, codling moth, macadamia nut borer and bollworm, including the patented CrpeNPV, with European development and distribution partnered with Oro Agri (Rovensa).
Threat of New Entrants – Medium
Registration of a new baculovirus active substance requires significant time and investment, and in vivo production know-how, insect rearing capabilities and quality control systems are difficult to replicate.
Proprietary virus isolates and existing registrations held by established producers create barriers to entry.
However, simpler regulatory pathways for biologicals in some countries, public research support (e.g., technology licensing from Embrapa in Brazil) and growing investor interest in biologicals are enabling new regional producers to enter.
Bargaining Power of Suppliers – Low
Most inputs, such as diet ingredients and formulation additives, are widely available commodities with many suppliers.
Leading producers maintain their own virus banks and insect colonies, reducing dependence on external suppliers for critical biological inputs.
Bargaining Power of Buyers – Medium
Large growers, cooperatives and agrochemical distributors purchase in volume and can negotiate prices, especially in field crops.
Buyers can choose between baculoviruses and chemical or other biological alternatives for many pests.
For specific pests with few effective alternatives or under strict residue requirements, buyers have limited substitution options, which moderates their bargaining power.
Threat of Substitutes – High
Synthetic insecticides, including newer diamide and spinosyn chemistries, offer broader spectrum and faster action at competitive prices.
Other biologicals such as Bacillus thuringiensis products, entomopathogenic fungi and pheromone-based mating disruption compete for the same pests and IPM budgets.
Insect-resistant transgenic crops (Bt cotton, maize and soybean) reduce the need for foliar caterpillar control in some markets.
Intensity of Competitive Rivalry – Medium
A small number of specialist producers compete internationally, while numerous regional producers compete on price in local markets, particularly in Brazil, China and India.
Competition is based on isolate portfolio, registrations, product quality, price and distribution reach; acquisitions by large agrochemical companies are intensifying rivalry.
Threat of New Entrants: Medium; Registration costs and production know-how versus simplified biological pathways and public technology licensing.
Bargaining Power of Suppliers: Low; Commodity inputs; in-house virus banks and insect colonies.
Bargaining Power of Buyers: Medium; Volume buyers in field crops; limited alternatives for specific pests and residue-sensitive crops.
Threat of Substitutes: High; Synthetic insecticides, Bt products, fungi, pheromones and Bt crops.
Competitive Rivalry: Medium; Few global specialists and many regional producers; consolidation underway.
Market estimates by geography (2032)
InsightNorth America leads with $349.79M by 2032, while Asia Pacific is projected to grow fastest at a 12.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $155.80M | $232.94M | $349.79M | 8.4% | 30% |
| Europe | $110.77M | $171.00M | $262.34M | 9.0% | 23% |
| Asia Pacific | $75.65M | $137.84M | $244.85M | 12.5% | 21% |
| Latin America | $90.06M | $154.06M | $251.85M | 10.8% | 22% |
| Middle East & Africa | $18.01M | $31.19M | $57.13M | 12.2% | 5% |
| Total | $450.29M | $727.03M | $1.17B | 10.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.17B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Liquid (SC) | $862.81M | 11.0% | 74% |
| Dry | $303.15M | 7.6% | 26% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Baculovirus Biopesticides Market covering market dynamics, competitive landscape, and strategic outlook.
The Baculovirus Biopesticides Market market is projected to reach $1.17B by 2032, growing at 10.0% CAGR. The Liquid (SC) segment holds the largest share.
The Global Baculovirus Biopesticides Market is shaped by a combination of agronomic, regulatory, economic and technological factors. Rising resistance of key caterpillar pests to synthetic insecticides and to Bt crop traits, stricter limits on chemical residues, the spread of invasive pests and government support for biological inputs are stimulating demand. Against this, the narrow pest spectrum and slower action of baculovirus products, production costs and limited awareness among growers act as restraints. This chapter analyses these dynamics. The growth factor analysis in Section 4.2 presents scores that are analyst assessments, based on secondary research and industry interviews, of the impact of each factor on market growth over the forecast period, on a scale of 1 (very low) to 10 (very high).
Rising Insecticide Resistance and the Need for Resistance Management
Resistance to synthetic insecticides and to Bt crop traits is one of the strongest drivers of baculovirus adoption. Helicoverpa armigera, one of the most damaging crop pests globally, has developed resistance to pyrethroids, organophosphates and other chemical classes in many regions, and its incursion into Brazil in 2012–2013 caused severe losses in soybean and cotton that triggered emergency approvals of biological products, including HearNPV-based insecticides. Fall armyworm (Spodoptera frugiperda) has evolved field resistance to several Bt proteins in the Americas, while pink bollworm resistance to Bt cotton has been documented in India. Because baculoviruses have a mode of action entirely different from chemical insecticides, the Insecticide Resistance Action Committee (IRAC) classifies them in a separate group (Group 31), and they are increasingly recommended in rotation with chemical products to delay resistance. In large-acre soybean, maize and cotton production, NPV products are now applied as resistance management partners rather than as niche organic inputs, which has significantly broadened the addressable market. This shift is particularly visible in Brazil, where baculovirus products are applied on millions of hectares of soybean each season.
Regulatory Pressure on Synthetic Pesticides and Support for Biocontrol
Regulators in major agricultural markets are restricting older synthetic insecticides while creating faster or simpler pathways for low-risk biological products. In the European Union, Regulation (EC) No 1107/2009 has led to the non-renewal of numerous chemical active substances, while baculoviruses such as CpGV and PhopGV have been approved as low-risk active substances. In 2022 the EU adopted dedicated data requirements and approval criteria for micro-organisms (Regulations (EU) 2022/1438 and 2022/1439), designed to make the assessment of microbial products more appropriate and predictable. Brazil enacted a new pesticides law in 2023 (Law No. 14,785) and a dedicated bioinputs law (Law No. 15,070) in December 2024, which provides a specific legal framework for the production, registration and use of biological inputs. In the United States, biopesticides are reviewed by a dedicated division of the EPA and generally require smaller data packages than conventional pesticides. These measures lower entry barriers for new baculovirus products and encourage growers to substitute chemical insecticides with biological alternatives.
Spread of Invasive Lepidopteran Pests
The globalisation of agricultural trade and changing climatic conditions have accelerated the spread of invasive caterpillar pests. Fall armyworm, native to the Americas, was first reported in West and Central Africa in 2016 and spread rapidly across sub-Saharan Africa before reaching India in 2018 and then much of Asia and Oceania, including China and Australia. The pest attacks maize, sorghum, rice, cotton and vegetables, and national governments and international organisations have promoted IPM approaches that include biological control. Similarly, Tuta absoluta, the tomato leafminer, has spread from South America to Europe, Africa, the Middle East and Asia. The emergence of these pests in new regions has created immediate demand for effective, safe control tools and has encouraged the registration of SfMNPV, PhopGV and other baculovirus products in new markets. Warmer temperatures are also extending the number of pest generations per season in temperate zones, increasing the frequency of insecticide applications and the need for resistance-management partners.
Growth of Residue-Sensitive Horticulture and Organic Production
Fruit and vegetable growers face increasingly strict residue requirements from regulators, export markets and food retailers, many of which impose limits on the number and level of detectable residues that are tighter than legal maximum residue limits. Baculovirus products leave no residues of concern, typically carry very short or no pre-harvest intervals and are, in many jurisdictions, exempt from the requirement to set maximum residue limits. This makes them particularly attractive for crops harvested shortly after treatment, such as tomatoes, peppers, leafy vegetables and berries, and for export-oriented producers. Baculovirus products are also permitted in certified organic production in major markets, and the continued expansion of organic farmland and organic food sales in Europe and North America supports steady demand. CpGV, for example, has become a standard tool for codling moth control in both organic and conventional apple and pear orchards in Europe and North America.
Large-Acre Row Crops in Latin America and Asia
The successful adoption of NPV products in Brazilian soybean, maize and cotton demonstrates that baculoviruses can be used profitably on a very large scale. Similar opportunities exist in Argentina, Paraguay, India, China and other countries with large areas of field crops affected by Helicoverpa, Spodoptera and Chrysodeixis species. Integration of baculovirus applications into conventional spray programmes, supported by agronomic advice and competitive pricing, could unlock substantial new volumes.
New Isolates and Multi-Virus Combination Products
The development of new virus isolates offers solutions to emerging problems, such as codling moth populations that have become resistant to the original CpGV isolate in parts of Europe; resistance-breaking isolates have already been commercialised. Combination products containing two or more viruses, such as mixtures targeting Helicoverpa, Chrysodeixis and Spodoptera species simultaneously, broaden the pest spectrum and address one of the main limitations of single-virus products. Continued investment in virus discovery and formulation is expected to expand the range of crops and pests that can be addressed.
Integration with Major Agrochemical Distribution Networks
Large crop protection companies are building biological portfolios through acquisitions and partnerships, as illustrated by BASF's acquisition of AgBiTech in 2026 and UPL's distribution partnership with AgBiTech. Access to the extensive sales, technical support and distribution networks of these companies can accelerate market penetration of baculovirus products, especially in regions where specialist producers have limited presence. Packaging baculoviruses with chemical and other biological products into integrated crop programmes also creates commercial opportunities.
Narrow Host Range and Slower Speed of Kill
The high specificity of baculoviruses, while an environmental advantage, limits their commercial appeal. Most viruses are active against a single pest species or a small group of closely related species, so growers facing a complex of pests may need several products or a supplementary chemical insecticide. Baculoviruses also act more slowly than contact insecticides: infected larvae typically continue to feed for several days before dying, and the products are most effective against early larval stages. This requires accurate pest monitoring and well-timed applications, which is a barrier for growers accustomed to the rapid knockdown of synthetic insecticides.
Production Cost and Scalability Constraints
Commercial baculoviruses are produced in vivo by rearing large numbers of host insects on artificial diet, infecting them and harvesting the virus. This process is labour-intensive, requires strict quality control to prevent contamination and is difficult to scale quickly in response to pest outbreaks. Cell-culture (in vitro) production has been researched for decades but is not yet widely used commercially for crop protection products. As a result, production costs per hectare treated can be higher than for generic chemical insecticides, which constrains adoption in price-sensitive field crops and smallholder markets.
Limited Field Persistence and Grower Awareness
Occlusion bodies are inactivated by ultraviolet radiation, so field persistence on exposed foliage is often only a few days, and repeated applications may be needed under high pest pressure. Some formulations also require cool storage to maintain potency. In many developing markets, awareness among growers and retailers of how to use baculovirus products effectively remains limited, and extension services are under-resourced. Inconsistent results from poor timing, inadequate storage or low-quality products can undermine confidence in the technology.
Consolidation and Strategic Acquisitions
The industry is consolidating as specialist producers and large agrochemical groups seek scale, registrations and geographic reach. Notable transactions since 2022 include Andermatt's acquisitions of BioTEPP in Canada and a majority stake in Agricheck in Argentina, Biobest's acquisition of Biotrop in Brazil and BASF's acquisition of AgBiTech. Consolidation is expected to continue as companies compete for registered virus isolates and production capacity.
Shift from Niche to Mainstream Use
Baculovirus products are moving from niche use in organic and specialty crops to mainstream use in conventional agriculture, where they are positioned as partners for resistance management and residue reduction. This trend is changing product requirements, with greater emphasis on cost per hectare, tank-mix compatibility and stable liquid formulations suited to large spray equipment.
Evolving Regulatory Frameworks for Microbials
Regulatory frameworks are being adapted to microbial products, including the EU's 2022 data requirements for micro-organisms and Brazil's 2024 bioinputs law. While these changes are expected to improve the predictability of approvals, the transition creates uncertainty in the short term, and registration timelines and data requirements still differ significantly from country to country.
Quality Assurance and Resistance to Viruses
Quality assurance remains a challenge, particularly where low-quality or unregistered products and on-farm multiplication compete with registered products. Field resistance of codling moth to certain CpGV isolates, first observed in Europe in the mid-2000s, has also shown that baculoviruses are not immune to resistance development, highlighting the need for isolate diversity and stewardship programmes.
The value chain of the baculovirus biopesticides market comprises four main stages:
Raw materials and inputs: The key inputs are virus seed stocks (master and working banks of characterised isolates), host insect colonies, artificial insect diet ingredients (soy flour, wheat germ, agar, yeast, vitamins and preservatives), and formulation additives such as UV protectants, wetting agents, dispersants and carriers. Access to proprietary isolates and healthy insect colonies is a key source of competitive advantage.
Manufacturing: Production involves mass rearing of host larvae, inoculation with virus, incubation, harvesting of infected larvae, extraction and purification of occlusion bodies, quantification and quality control (potency bioassays and microbial contamination testing), and formulation into liquid suspension concentrates or dry products. Manufacturing is concentrated among specialist producers, with dedicated facilities in Switzerland, the United States, Australia, Brazil, South Africa, China and India.
Distribution and channels: Products reach users through national distributors, agrochemical companies under licensing or co-marketing agreements, agricultural retailers and cooperatives, and direct sales to large growers. Technical support and grower education are integral to the distribution stage given the need for correct timing and handling.
End users: End users include fruit and vegetable growers, large-scale soybean, maize and cotton producers, organic farms, greenhouse operators, forestry agencies and plantation owners. Public agencies also procure baculovirus products for area-wide pest management and forest protection programmes.
North America
In the United States, baculovirus products are regulated as microbial pesticides under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) by the EPA's Office of Pesticide Programs, where the Biopesticides and Pollution Prevention Division reviews biopesticide applications. Data requirements for microbial pesticides are set out in 40 CFR Part 158, Subpart V, and tolerance exemptions for residues are established under the Federal Food, Drug, and Cosmetic Act. Products intended for organic production must comply with the USDA National Organic Program. In Canada, products are registered by Health Canada's Pest Management Regulatory Agency (PMRA) under the Pest Control Products Act. In Mexico, pesticide registration involves COFEPRIS together with the agriculture and environment authorities, with SENASICA overseeing plant health.
Europe
In the European Union, active substances are approved at EU level under Regulation (EC) No 1107/2009, with risk assessment by EFSA, and plant protection products are authorised by Member States. Several baculoviruses, including CpGV and PhopGV, are approved, and some qualify as low-risk active substances, which benefit from longer approval periods and faster product authorisation. Regulations (EU) 2022/1438 and 2022/1439 introduced specific approval criteria and data requirements for micro-organisms, applicable from November 2022. Directive 2009/128/EC on the sustainable use of pesticides requires Member States to promote integrated pest management and non-chemical methods. Maximum residue limits are governed by Regulation (EC) No 396/2005. In Great Britain, pesticides are regulated by the Health and Safety Executive under retained and amended legislation following the UK's exit from the EU.
Asia Pacific
In China, pesticides are registered by the Institute for the Control of Agrochemicals of the Ministry of Agriculture and Rural Affairs (ICAMA) under the Regulations on Pesticide Administration. In India, biopesticides are registered by the Central Insecticides Board and Registration Committee (CIB&RC) under the Insecticides Act, 1968, which provides specific guidelines for the registration of baculovirus products. In Japan, agricultural chemicals, including microbial pesticides, are registered under the Agricultural Chemicals Regulation Act administered by the Ministry of Agriculture, Forestry and Fisheries. In Australia, the Australian Pesticides and Veterinary Medicines Authority (APVMA) registers agricultural chemical products under the Agricultural and Veterinary Chemicals Code.
Latin America
In Brazil, pesticides are regulated under Law No. 14,785 of 2023, which replaced the previous pesticides law, while the bioinputs law (Law No. 15,070 of December 2024) establishes a specific framework for the production, registration, commercialisation and use of biological inputs, including on-farm production for own use. The Ministry of Agriculture and Livestock (MAPA) coordinates registration and maintains the AGROFIT product database. In Argentina, plant protection products are registered by the National Agri-Food Health and Quality Service (SENASA). In Chile, the Agricultural and Livestock Service (SAG) is responsible for pesticide authorisation.
Middle East & Africa
In South Africa, agricultural remedies, including biopesticides, are registered under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act (Act No. 36 of 1947), administered by the national Department of Agriculture. In the Gulf states, pesticide registration is managed by the agriculture and environment ministries, such as the Ministry of Environment, Water and Agriculture in Saudi Arabia and the Ministry of Climate Change and Environment in the UAE. Many African countries are working towards regional harmonisation of pesticide registration through regional economic communities.
Mar 2022: Mitsui & Co. (Certis); Merger; Mitsui merged Certis Europe and Belchim Crop Protection to form Certis Belchim B.V., strengthening its European crop protection and biologicals platform.
May 2022: UPL (NPP) / AgBiTech; Partnership; UPL's NPP unit began distributing AgBiTech's NPV products Heligen and Fawligen in California, Arizona and Hawaii.
Aug 2022: Andermatt Group; Acquisition; Andermatt became the 80% owner of BIOinput d.o.o. in Croatia.
Sep 2022: Andermatt Group; Expansion; Andermatt established Andermatt Mexico as a new subsidiary.
Sep 2022: Koppert / AgBiTech; Agreement; AgBiTech transferred the Brazilian registration of its SfMNPV product to Koppert, which markets it as Buick for fall armyworm control.
Jan 2023: River Bioscience / Oro Agri (Rovensa); Partnership; Development and exclusive European distribution agreement for River Bioscience's CrpeNPV baculovirus.
Jun 2023: Andermatt Group; Product launch; Launch of Plutex, a Plutella xylostella granulovirus (PlxyGV) product for diamondback moth control.
Aug 2023: Simbiose Agro; Investment / Expansion; Announced an investment programme of more than BRL 300 million at its Cruz Alta facility, together with plans for international expansion.
Dec 2023: Biobest Group; Acquisition; Completed the acquisition of approximately 85% of Biotrop (Brazil) at an enterprise value of BRL 2.8 billion.
Jul 2024: Andermatt Group; Acquisition; Acquired BioTEPP Inc. (Canada), producer of the CpGV product Virosoft CP4.
Oct 2024: Andermatt Group; Acquisition; Acquired an 80% shareholding in Agricheck S.R.L., expanding its presence in Argentina.
Nov 2024: AgBiTech; Market expansion; Reported that its baculovirus products had been used on 5 million hectares in Brazil.
Feb 2025: Andermatt Group; Regulatory approval; Phthorimaea operculella granulovirus (PhopGV), the active ingredient of Tutavir, was approved as a low-risk active substance in the EU.
Feb 2025: Andermatt Group; Expansion; Established Andermatt Italia S.r.l. as a new subsidiary.
2025: Promip; Investment; Raised a BRL 20 million Series A round, with most of the funds earmarked for production capacity and research and development.
Jan 2026: BASF / AgBiTech; Acquisition; BASF announced an agreement to acquire AgBiTech.
Mar 2026: BASF / AgBiTech; Acquisition; BASF completed the acquisition of AgBiTech, adding its NPV portfolio to BASF Agricultural Solutions.
Apr 2026: Andermatt Group; Regulatory approval; Lower application rates of Helicovex (HearNPV) were approved in Australia.
Political
National policies to reduce dependence on synthetic pesticides and imported agrochemicals, such as Brazil's national bioinputs policy and China's action plan to curb growth in pesticide use, support the adoption of biologicals.
Government-funded IPM and invasive pest response programmes, particularly for fall armyworm in Africa and Asia, create institutional demand.
Economic
Commodity price cycles affect growers' willingness to invest in premium crop protection products, particularly in soybean, maize and cotton.
The price premium of export-quality, residue-free produce supports the economics of baculovirus use in high-value horticulture.
Currency fluctuations in major emerging markets influence import costs and the USD value of local sales.
Social
Growing consumer concern about pesticide residues and environmental impacts drives demand for biologically produced food.
Increasing awareness among growers of resistance problems and of the benefits of preserving natural enemies supports IPM adoption.
Farm worker safety considerations favour products with short re-entry intervals and low toxicity.
Technological
Advances in formulation, including UV protectants and stable suspension concentrates, improve field performance and shelf life.
Genomic characterisation of virus isolates supports the development of new and resistance-breaking strains and multi-virus products.
Research on in vitro (cell culture) production could reduce costs and improve scalability in the long term.
Environmental
Baculoviruses are highly specific and safe for pollinators, natural enemies, aquatic organisms and vertebrates, supporting biodiversity objectives.
Climate change is expanding the range and number of generations of lepidopteran pests, increasing the need for sustainable control tools.
Legal
Dedicated regulatory frameworks for microbials, such as the EU's 2022 data requirements for micro-organisms and Brazil's 2024 bioinputs law, are shaping market access.
Access and benefit-sharing rules under the Nagoya Protocol can affect the collection and commercial use of virus isolates from different countries.
Intellectual property protection for virus isolates and formulations remains limited compared with synthetic molecules, increasing reliance on registration data protection.
Profiles of 108 companies operating in the Baculovirus Biopesticides Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
4 interactive charts drawn from the Baculovirus Biopesticides Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Baculovirus Biopesticides Market By Target Pest
Global Baculovirus Biopesticides Market By Crop Type
Global Baculovirus Biopesticides Market By Formulation
Global Baculovirus Biopesticides Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)